Robinson Warren 4
4 · BioNano Genomics, Inc · Filed Oct 3, 2018
Insider Transaction Report
Form 4
Robinson Warren
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-10-01+64,640→ 64,640 totalExercise: $7.77Exp: 2028-09-30→ Common Stock (64,640 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option vest and become exercisable on October 1, 2018, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.